Allstate (NYSE:ALL) Price Target Raised to $195.00 at Evercore ISI

Allstate (NYSE:ALL) had its price objective upped by Evercore ISI from $191.00 to $195.00 in a research report released on Wednesday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the insurance provider’s stock.

Other analysts have also issued reports about the stock. TD Cowen upped their target price on shares of Allstate from $193.00 to $224.00 and gave the stock a buy rating in a research note on Tuesday, September 3rd. Barclays began coverage on shares of Allstate in a research report on Wednesday, September 4th. They issued an underweight rating and a $175.00 price objective on the stock. The Goldman Sachs Group lifted their price objective on shares of Allstate from $199.00 to $204.00 and gave the stock a buy rating in a research report on Thursday, August 15th. Wells Fargo & Company dropped their target price on Allstate from $177.00 to $175.00 and set an equal weight rating on the stock in a report on Friday, August 16th. Finally, Bank of America lifted their price target on Allstate from $213.00 to $226.00 and gave the stock a buy rating in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Allstate currently has a consensus rating of Moderate Buy and a consensus target price of $199.41.

Allstate Price Performance

Allstate stock opened at $184.82 on Wednesday. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49. Allstate has a 52-week low of $113.04 and a 52-week high of $193.97. The firm has a market cap of $48.78 billion, a PE ratio of 40.80, a price-to-earnings-growth ratio of 1.81 and a beta of 0.48. The company’s 50 day moving average is $183.60 and its two-hundred day moving average is $172.72.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business had revenue of $15.71 billion for the quarter, compared to analysts’ expectations of $14.04 billion. During the same period last year, the firm earned ($4.42) earnings per share. The company’s revenue for the quarter was up 12.4% compared to the same quarter last year. On average, research analysts expect that Allstate will post 15.2 EPS for the current fiscal year.

Allstate Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Investors of record on Friday, August 30th were paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend was Friday, August 30th. Allstate’s dividend payout ratio is currently 81.24%.

Insider Buying and Selling at Allstate

In other Allstate news, insider Suren Gupta sold 45,775 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $177.28, for a total transaction of $8,114,992.00. Following the completion of the sale, the insider now directly owns 89,930 shares of the company’s stock, valued at $15,942,790.40. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Suren Gupta sold 45,775 shares of the business’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $177.28, for a total transaction of $8,114,992.00. Following the sale, the insider now owns 89,930 shares in the company, valued at $15,942,790.40. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 238,305 shares of company stock worth $43,082,657. 1.80% of the stock is owned by company insiders.

Institutional Trading of Allstate

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Rise Advisors LLC purchased a new stake in shares of Allstate in the 1st quarter worth about $26,000. Northwest Investment Counselors LLC acquired a new stake in shares of Allstate in the first quarter valued at approximately $26,000. Versant Capital Management Inc increased its stake in shares of Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Allstate during the 2nd quarter worth approximately $38,000. Finally, MCF Advisors LLC lifted its stake in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after buying an additional 84 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.